The potential benefits of multivessel PCI in STEMI may not extend to people older than 65 years, observational US data suggest. The analysis, using a statistical method that aims to remove unmeasured ...
Treating patients thought to have STEMI with P2Y12 inhibitors before they get to the hospital does not reduce their risk of major adverse cardiovascular or cerebrovascular events, data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback